Change to FIT increased CRC screening rates: evaluation of a US screening outreach program.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMC 3631273)

Published in Am J Manag Care on October 01, 2012

Authors

Elizabeth G Liles1, Nancy Perrin, Ana Gabriela Rosales, Adrianne C Feldstein, David H Smith, David M Mosen, Jennifer L Schneider

Author Affiliations

1: Center for Health Research, Kaiser Permanente, Portland, OR 97227-1110, USA. Elizabeth.G.Liles@kp.org

Articles citing this

Randomized, controlled trial of a multimodal intervention to improve cancer screening rates in a safety-net primary care practice. J Gen Intern Med (2013) 1.20

Evaluation of a home-based colorectal cancer screening intervention in a rural state. J Rural Health (2013) 0.99

Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes. BMC Cancer (2014) 0.95

Test characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy. J Med Screen (2014) 0.81

Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study. BMC Public Health (2015) 0.79

Human Blood Autoantibodies in the Detection of Colorectal Cancer. PLoS One (2016) 0.76

Effect of Ambient Temperature Variations on Positivity of Manual Fecal Immunochemical Tests. J Prim Care Community Health (2015) 0.75

Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT. Eur J Cancer Prev (2014) 0.75

Colorectal cancer screening at community health centers: A survey of clinicians' attitudes, practices, and perceived barriers. Prev Med Rep (2015) 0.75

Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust. BMC Cancer (2016) 0.75

Community-Based Colorectal Cancer Screening in a Rural Population: Who Returns Fecal Immunochemical Test (FIT) Kits? J Rural Health (2016) 0.75

Articles cited by this

Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer (2010) 13.27

The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med (2000) 13.19

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90

Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med (2004) 6.42

Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer (2004) 6.41

Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev (2007) 5.63

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology (2008) 4.68

A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med (2007) 3.41

Practical clinical trials for translating research to practice: design and measurement recommendations. Med Care (2005) 3.38

Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol (2010) 3.29

Predictors of nonadherence to screening colonoscopy. J Gen Intern Med (2005) 2.80

Vital signs: colorectal cancer screening among adults aged 50-75 years - United States, 2008. MMWR Morb Mortal Wkly Rep (2010) 2.75

Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg (2008) 2.75

A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer (2007) 2.64

Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology (2004) 2.63

Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut (2002) 2.50

Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol (2003) 2.43

Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med (2006) 2.31

Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen (2007) 2.30

Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J Community Health (2000) 2.26

Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol (2004) 2.14

Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer (2010) 2.05

Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med (2003) 2.05

Disparities in colon cancer screening in the Medicare population. Arch Intern Med (2007) 2.04

Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med (2005) 1.94

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer (2009) 1.93

Patient-physician colorectal cancer screening discussions and screening use. Am J Prev Med (2006) 1.87

Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Prev Med (2010) 1.79

Tailored navigation in colorectal cancer screening. Med Care (2008) 1.79

Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med (2007) 1.78

Colorectal cancer screening barriers and facilitators in older persons. Prev Med (2009) 1.73

Patient preferences for gender of endoscopists. Gastrointest Endosc (2002) 1.62

A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen (2003) 1.62

Automated telephone calls improved completion of fecal occult blood testing. Med Care (2010) 1.50

Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med (2010) 1.47

A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer (2004) 1.45

Link between a preference for women colonoscopists and social status in Korean women. Gastrointest Endosc (2007) 1.44

Colorectal carcinoma screening procedure use among primary care patients. Cancer (2005) 1.29

Underuse of colorectal cancer screening in a cohort of Medicare beneficiaries. Cancer (2008) 1.29

Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med (2010) 1.27

The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev (2008) 1.22

The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial. J Med Screen (2005) 1.20

Women patients' preference for women physicians is a barrier to colon cancer screening. Gastrointest Endosc (2005) 1.20

Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology (1999) 1.19

Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc (2002) 1.16

Correlates of colorectal cancer testing in Massachusetts men and women. Prev Med (2003) 1.13

Receipt of preventive services by elders based on composite measures, 1997-2004. Am J Prev Med (2007) 1.13

Determinants of colorectal cancer screening in women undergoing mammography. Am J Gastroenterol (2003) 1.10

Applying a stage model of behavior change to colon cancer screening. Prev Med (2005) 1.10

Comparing colorectal cancer screening and immunization status in older americans. Am J Prev Med (2007) 1.07

Predictors of colorectal cancer screening from patients enrolled in a managed care health plan. Cancer (2008) 1.05

Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am J Gastroenterol (2007) 1.04

Sociodemographic differences in use of preventive services by women enrolled in Medicare+Choice plans. Prev Med (2004) 0.99

Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy? Med Care (2008) 0.98

Colorectal cancer screening mode preferences among US veterans. Prev Med (2009) 0.98

Are older adults up-to-date with cancer screening and vaccinations? Prev Chronic Dis (2005) 0.97

Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat (2005) 0.89

Importance of gender, socioeconomic status, and history of abuse on patient preference for endoscopist. Am J Gastroenterol (2009) 0.84

Preferences for ethnicity and sex of endoscopists in a Hispanic population in the United States. Gastrointest Endosc (2011) 0.83

Women are different from men. Gastrointest Endosc (2002) 0.80

Issues related to colorectal cancer and colorectal cancer screening practices in women. Gastroenterol Clin North Am (2011) 0.76

Articles by these authors

Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med (2004) 7.79

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25

Prescription drug use in pregnancy. Am J Obstet Gynecol (2004) 4.92

Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA (2013) 4.67

Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA (2013) 3.30

Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res (2012) 2.85

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA (2011) 2.77

Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci (2006) 2.73

Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol (2007) 2.61

Over-the-counter and compounded vitamin D: is potency what we expect? JAMA Intern Med (2013) 2.53

Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care (2005) 2.33

Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc (2006) 2.33

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial. J Bone Miner Res (2010) 2.29

Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med (2003) 2.19

How to design computerized alerts to safe prescribing practices. Jt Comm J Qual Saf (2004) 2.11

Incidence and risk factors for venous thromboembolic disease in podiatric surgery. Chest (2008) 2.09

The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes (2008) 2.03

The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Arch Intern Med (2006) 1.91

Estimating utility data from clinical indicators for patients with stable angina. Eur J Health Econ (2005) 1.78

Patient Assessment of Chronic Illness Care (PACIC) and improved patient-centered outcomes for chronic conditions. J Gen Intern Med (2007) 1.78

Comparison of sleep parameters from actigraphy and polysomnography in older women: the SOF study. Sleep (2008) 1.75

Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf (2006) 1.73

A primary care-based, multicomponent lifestyle intervention for overweight adolescent females. Pediatrics (2012) 1.73

Reducing warfarin medication interactions: an interrupted time series evaluation. Arch Intern Med (2006) 1.67

Actigraphy scoring reliability in the study of osteoporotic fractures. Sleep (2005) 1.67

Is patient activation associated with future health outcomes and healthcare utilization among patients with diabetes? J Ambul Care Manage (2009) 1.65

AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol (2008) 1.57

Gender difference in the prevalence of eating disorder symptoms. Int J Eat Disord (2009) 1.56

Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis (2008) 1.54

Trends in elective labor induction for six United States health plans, 2001-2007. J Womens Health (Larchmt) (2014) 1.54

Automated telephone calls improved completion of fecal occult blood testing. Med Care (2010) 1.50

Initial efficacy of MI, TTM tailoring and HRI's with multiple behaviors for employee health promotion. Prev Med (2007) 1.50

Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs. J Manag Care Pharm (2006) 1.46

Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product. Am Heart J (2004) 1.44

Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly. Eur Heart J (2006) 1.42

Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients. Ann Pharmacother (2006) 1.42

Vitamin D levels and menopause-related symptoms. Menopause (2014) 1.41

Computerized prescribing alerts and group academic detailing to reduce the use of potentially inappropriate medications in older people. J Am Geriatr Soc (2006) 1.40

Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am (2003) 1.40

Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf (2009) 1.38

Improved therapeutic monitoring with several interventions: a randomized trial. Arch Intern Med (2006) 1.37

The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int (2005) 1.35

Weight change in diabetes and glycemic and blood pressure control. Diabetes Care (2008) 1.34

Predicting renal replacement therapy and mortality in CKD. Am J Kidney Dis (2007) 1.34

Validity of the Asthma Control Test completed at home. Am J Manag Care (2007) 1.25

Quantitative trait loci on chromosomes 2p, 4p, and 13q influence bone mineral density of the forearm and hip in Mexican Americans. J Bone Miner Res (2003) 1.25

Systolic blood pressure and mortality among older community-dwelling adults with CKD. Am J Kidney Dis (2010) 1.24

Does a history of non-vertebral fracture identify women without osteoporosis for treatment? J Gen Intern Med (2008) 1.23

Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc (2005) 1.22

Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf (2008) 1.21

Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf (2012) 1.20

Cost-effectiveness of an intervention to prevent depression in at-risk teens. Arch Gen Psychiatry (2005) 1.19

Genetic and environmental determinants of bone mineral density in Mexican Americans: results from the San Antonio Family Osteoporosis Study. Bone (2003) 1.19

The protective role of tangible support on post-traumatic stress disorder symptoms in urban women survivors of violence. Res Nurs Health (2007) 1.16

The individual and program impacts of eliminating Medicaid dental benefits in the Oregon Health Plan. Am J Public Health (2011) 1.16

Effect of a multimodal reminder program on repeat mammogram screening. Am J Prev Med (2009) 1.13

Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc (2013) 1.12

Healthy Moms, a randomized trial to promote and evaluate weight maintenance among obese pregnant women: study design and rationale. Contemp Clin Trials (2012) 1.11

A comparison of two methods for identifying frail Medicare-aged persons. J Am Geriatr Soc (2002) 1.10

A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. Arch Intern Med (2008) 1.09

Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension (2007) 1.09

Medication Exposure in Pregnancy Risk Evaluation Program. Matern Child Health J (2012) 1.08

Effect of a patient panel-support tool on care delivery. Am J Manag Care (2010) 1.08

Risk for reassault in abusive female same-sex relationships. Am J Public Health (2008) 1.06

Cost-effectiveness of guided self-help treatment for recurrent binge eating. J Consult Clin Psychol (2010) 1.06

Efficacy of a group-based dietary intervention for limiting gestational weight gain among obese women: a randomized trial. Obesity (Silver Spring) (2014) 1.05

The relationship between asthma-specific quality of life and asthma control. J Asthma (2007) 1.05

Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations. Pharmacoepidemiol Drug Saf (2009) 1.03

Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health (2013) 1.03

Use of health information technology to improve medication adherence. Am J Manag Care (2011) 1.03

Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. Nephrology (Carlton) (2006) 1.01

Impact of comorbidities on mortality in managed care patients with CKD. Am J Kidney Dis (2006) 1.01

Effectiveness of bisphosphonate therapy in a community setting. Bone (2008) 1.01

Correlates of higher-dose opioid medication use for low back pain in primary care. J Pain (2012) 0.99

Computerized aid improves safety decision process for survivors of intimate partner violence. J Interpers Violence (2009) 0.99

Self-reported health and functional status information improves prediction of inpatient admissions and costs. Am J Manag Care (2011) 0.99

First-generation linkage map of the gray, short-tailed opossum, Monodelphis domestica, reveals genome-wide reduction in female recombination rates. Genetics (2004) 0.98

Cognitive behavioral guided self-help for the treatment of recurrent binge eating. J Consult Clin Psychol (2010) 0.97

Potential drug-drug interactions in the outpatient setting. Med Care (2006) 0.96

Risk factors predicting the development of widespread pain from chronic back or neck pain. J Pain (2010) 0.96

Localization of genes that control LDL size fractions in baboons. Atherosclerosis (2003) 0.95

Evidence of the peripheral inflammatory response in patients with transient ischemic attack. J Stroke Cerebrovasc Dis (2007) 0.95

Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med (2013) 0.93

Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Nephrology (Carlton) (2009) 0.93

Electronic medical records and prevention quality: the prevention index. Am J Prev Med (2007) 0.93

Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study. J Am Geriatr Soc (2013) 0.93

Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med (2010) 0.93

Type 2 diabetes is associated with increased bone mineral density in Mexican-American women. Arch Med Res (2003) 0.93

Screening for binge eating disorders using the Patient Health Questionnaire in a community sample. Int J Eat Disord (2010) 0.92

Nurse-coordinated care in CKD: time for translation into practice? Clin J Am Soc Nephrol (2011) 0.91